Brief: Senzime: New Study Confirms Effectiveness Of Tetragraph
Sept 7 (Reuters) - Senzime AB (publ) SEZI.ST :
* NEW US STUDY CONFIRMS THE EFFECTIVENESS OF TETRAGRAPH QUANTITATIVE NEUROMUSCULAR BLOCKADE
MONITOR FOR CHILDREN
* STUDY CONCLUDES THAT TETRAGRAPH, COMPANY'S ELECTROMYOGRAPHY (EMG)-BASED MONITOR, IS
EFFECTIVE
FOR MONITORING NEUROMUSCULAR BLOCKADE IN CHILDREN
Source text for Eikon: ID:nMFNzv9L5
Further company coverage: SEZI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona